Detrimental Antidepressant Drug–Drug Interactions: Are They Clinically Relevant?

被引:0
作者
Sheldon Preskorn
Steve Werder
机构
[1] University of Kansas School of Medicine-Wichita,Department of Psychiatry
来源
Neuropsychopharmacology | 2006年 / 31卷
关键词
antidepressants; drug–drug interactions; cytochrome ; 450 enzymes; serious adverse effects; polypharmacy;
D O I
暂无
中图分类号
学科分类号
摘要
This paper takes the position that detrimental drug–drug interactions (DDIs) involving antidepressants are clinically relevant. In doing so, it begins with a definition of the terms: drug–drug interaction, detrimental, and clinical relevance. It then discusses the issues of proof and provides an overview of the clinically relevant DDIs involving antidepressants. It also gives examples involving drugs besides antidepressants based on the premise that the underlying principles are applicable regardless of the therapeutic classes of the drugs involved.
引用
收藏
页码:1605 / 1612
页数:7
相关论文
共 111 条
  • [1] Ahmed I(1993)Possible interaction between fluoxetine and pimozide causing sinus bradycardia Can J Psychiatry 38 62-63
  • [2] Dagincourt PG(1997)Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine Pharmacopsychiatry 30 274-275
  • [3] Miller LG(1993)Possible monoamine oxidase inhibitor–serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings J Clin Psychopharmacol 13 312-320
  • [4] Shader RI(1994)Probable metabolic interaction between methadone and fluvoxamine in addict patients Ther Drug Monit 16 42-45
  • [5] Azaz LT(2005)The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation J Clin Psychiatry 66 15-27
  • [6] Danenberg HD(2001)Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus Eur J Clin Pharmacol 57 185-209
  • [7] Beasley CM(1998)A fatal drug interaction between clozapine and fluoxetine J Forensic Sci 43 1082-1085
  • [8] Masica DN(2002)Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St John's wort ( J Clin Psychopharmacol 22 46-54
  • [9] Heiligenstein JH(2005)) J Psych Prac 11 1-13
  • [10] Wheadon DE(1985)Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring Acta Neurol Scand 71 448-452